25 of the Best Pediatric Hematologist Oncologists Near Me

View the full list of Dr. Friehling's publications on PubMed. Her clinical expertise encompasses Acquired Amegakaryocytic Thrombocytopenia, Leukemia, Acute Lymphoblastic Leukemia (ALL), and Immune Thrombocytopenic Purpura (ITP). Dr. Friehling is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Friehling is currently accepting new patients.

Ramasubramanian (“Ram”) Kalpatthi, MD, is Clinical Research Director of Pediatric Sickle Cell Research and Director of PHO Medical Student and Resident Education at UPMC Children's Hospital of Pittsburgh. He is also a Visiting Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology.He earned his medical degree from Thanjavur Medical College in Thanjavur, India. He completed a Residency at All India Institute of Medical Sciences and Lincoln Medical Center followed by a fellowship at Nationwide Children's Hospital.Dr. Kalpatthi is nationally recognized for his excellence in the clinical care, clinical research, program development and leadership in the field of pediatric hematology oncology with special emphasis on sickle cell disease (SCD) and immune thrombocytopenia (ITP). His other clinical interests include therapeutic apheresis, immune hematological disorders, neonatal hematology, benign hematological disorders, and childhood leukemia.Also, he is a favorite among medical students, residents, and fellows due to his passion for teaching, guiding, and mentoring future generation of physicians. He has mentored medical students, residents, and fellows in completing clinical research projects that have been published and/or presented at national conferences such as the American Society of Hematology (ASH), the American Society of Pediatric Hematology/Oncology (ASPHO) and Pediatric Academic Societies (PAS) meeting. Several of his mentees received outstanding abstract achievement awards for their work and most of his mentees have published their research in leading medical journals.View the full list of Dr. Kalpatthi’s publications on PubMed. His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy. Dr. Kalpatthi is board certified in American Board Of Pediatrics. Dr. Kalpatthi is currently accepting new patients.

Dr. Dean is a hematologist-oncologist in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. She joined the hospital staff in 2021. She was previously an attending physician with Pediatric Specialists of Virginia in the Center for Cancer and Blood Disorders and with Children’s National Hospital. Dr. Dean was the director of the Long-Term Follow-Up program at Pediatric Specialists of Virginia and Children’s National Hospital and director of the neuro-oncology program at Pediatric Specialists of Virginia. She was also a senior physician on the leukemia and lymphoma team. She was an assistant professor in the Department of Pediatrics at George Washington University School of Medicine and Health Science. Dr. Dean has published peer-reviewed articles, authored book chapters and lectured both nationally and internationally. Her clinical and research interests include the impact of physical activity on overall function, cardiac function and quality of life in leukemia and lymphoma patients. Dr. Dean earned her medical degree from Wake Forest University in Winston-Salem, North Carolina. She completed an internship and residency in pediatrics and a fellowship in pediatric hematology-oncology at St. Louis Children’s Hospital/Washington University in St. Louis. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Classical Hodgkin Lymphoma, Immune Thrombocytopenic Purpura (ITP), and Neurofibromatosis Type 1 (NF1). Dr. Dean is board certified in American Board Of Pediatrics. Dr. Dean is currently accepting new patients.

Lisa Maurer, MD, PhD, is a pediatric oncologist with an interest in pediatric leukemia and lymphoma. She is also a physician-scientist in the Lucas/ McAllister Lab in the Rangos Research Center of the UPMC Children's Hospital of Pittsburgh. Currently, Dr. Maurer's research focus is on the role of GRK2 in inhibition of the MALT1 proto-oncoprotein in lymphomagenesis.Dr. Maurer earned her medical degree from University of Wisconsin School of Medicine and Public Health and her PhD from the University of Wisconsin-Madison. She completed an internship and residency at the University of California San Francisco followed by a fellowship at UPMC Children’s Hospital of Pittsburgh.She is a member of the American Society of Pediatric Hematology Oncology and the AACR.View the full list of Dr. Maurer’s publications on PubMed. Her clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Maurer is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Maurer is currently accepting new patients.

View the full list of Dr. Rapkin's publications on PubMed. His clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Rhabdoid Tumor, Non-Langerhans-Cell Histiocytosis, and Histiocytosis. Dr. Rapkin is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Rapkin is currently accepting new patients.

Felipe Bautista-Otanez is a Pediatric Hematologist Oncology provider practicing medicine in Charlotte, North Carolina. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Bautista-Otanez is currently accepting new patients.

View the full list of Dr. Seynnaeve’s publications on PubMed. Her clinical expertise encompasses Hereditary Spherocytosis. Dr. Seynnaeve is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Seynnaeve is currently accepting new patients.

View the full list of Dr. Nolfi's publications on PubMed. Her clinical expertise encompasses Anemia, Hemolytic Anemia, Hemolysis, Sickle Cell Disease, and Splenectomy. Dr. Nolfi-Donegan is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Nolfi-Donegan is currently accepting new patients.

View the full list of Dr. Bukowinski's publications on PubMed. His clinical expertise encompasses Desmoplastic Small Round Cell Tumor, Adult Soft Tissue Sarcoma, Leukemia, and Rhabdomyosarcoma. Dr. Bukowinski is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Bukowinski is currently accepting new patients.

Morgan Pines is a Pediatric Hematologist Oncology specialist and a Pediatrics provider practicing medicine in New Hyde Park, New York. His clinical expertise encompasses Hemoglobin E Disease, Thalassemia, Congenital Hemolytic Anemia, and Hemoglobinopathy. Dr. Pines is board certified in American Board Of Pediatrics. Dr. Pines is currently accepting new patients.

Dr. Koldobskiy is an Assistant Professor of Pediatric Oncology and Pediatric Neuro-Oncology at the Sidney Kimmel Comprehensive Cancer Center. He received his B.S. and M.S. from Yale University and M.D./Ph.D. in the Medical Scientist Training Program at Johns Hopkins, conducting his thesis research with Dr. Solomon Snyder in Pharmacology and Molecular Sciences. He completed his Pediatrics residency training at Johns Hopkins and his Pediatric Hematology and Oncology fellowship training in the joint Johns Hopkins/National Institutes of Health program. He studies epigenetic variability in childhood cancer. His clinical expertise encompasses Leukemia, Glioma, Gliomatosis Cerebri, and Teratoma of the Mediastinum. Dr. Koldobskiy is board certified in American Board Of Pediatrics. Dr. Koldobskiy is currently accepting new patients.

Dr. Mayer is a pediatric hematologist-oncologist in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. She specializes in the diagnosis and management of patients with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), Hodgkin lymphoma and non-Hodgkin lymphoma. She is also the medical director of the Vascular Anomalies and Birthmarks Program at the hospital. She cares for patients with benign and aggressive vascular tumors, lymphatic and venous malformations, and overgrowth syndromes. She was named the William A. Baumgartner Physician of the Year for Johns Hopkins All Children's in the 2024 Johns Hopkins Medicine Clinical Awards. She previously received the hospital’s Best Consulting Physician Award in 2017. Dr. Mayer is the author of more than 30 publications and two textbook chapters. She has presented over 22 research abstracts at national and international medical conferences. She is program director of a three-year fellowship training program in pediatric hematology-oncology on the St. Petersburg, Florida, campus. Dr. Mayer joined Johns Hopkins All Children’s in 1996. Dr. Mayer received her medical degree with honors from Dartmouth Medical School in New Hampshire. She completed her pediatric residency, hematology-oncology fellowship, and clinical research fellowship at Yale University School of Medicine in Connecticut. She is a fellow of the American Academy of Pediatrics and an active member and clinical researcher with Children’s Oncology Group, American Society of Pediatric Hematology-Oncology, and the International Society for the Study of Vascular Anomalies. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Evans Syndrome, Acute Monoblastic Leukemia (AmoL), and Teratoma of the Mediastinum. Dr. Mayer is board certified in American Board Of Pediatrics. Dr. Mayer is currently accepting new patients.

Jenny Ruiz, MD, specializes in pediatric hematology oncology and is board certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh, Pediatric Hematology/Oncology and is affiliated with UPMC Magee-Womens Hospital. Dr. Ruiz completed her fellowship at Children's Hospital of Philadelphia, residency at Columbia University, and medical education at Columbia University College of Physicians and Surgeons. Her clinical expertise encompasses Leukemia, Acute Lymphoblastic Leukemia (ALL), Ewing Sarcoma, and Osteosarcoma. Dr. Ruiz is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Ruiz is currently accepting new patients.

Scott Maurer, MD, is a pediatric palliative care physician and a pediatric oncologist. Dr. Maurer is certified in pediatrics, pediatric hematology/oncology, and hospice and palliative medicine by the American Board of Pediatrics. He is the chief of the division of palliative medicine and supportive care at UPMC Children’s Hospital of Pittsburgh and is an associate professor of pediatrics at the University of Pittsburgh School of Medicine. His clinical expertise encompasses Infantile Neutropenia, Rosai-Dorfman Disease, Pediatric Low-Grade Glioma (pLGG), and Leukemia. Dr. Maurer is board certified in American Board Of Pediatrics, American Board Of Pediatrics , and American Board Of Pediatrics . Dr. Maurer is currently accepting new patients.

Dr. Booth specializes in bone marrow transplant as a hematologist-oncologist at Johns Hopkins All Children’s Hospital in St. Petersburg, Florida. She joined the hospital staff in 2023. She earned her medical degree at Nova Southeastern University College of Osteopathic Medicine in Fort Lauderdale, Florida. She completed her residency at University of Florida, College of Medicine-Jacksonville and Wolfson Children’s Hospital in Jacksonville, Florida. She then completed a fellowship in pediatric hematology-oncology, followed by a fellowship in pediatric hematopoietic stem cell transplant, immunotherapy, at Phoenix Children’s Hospital and University of Arizona, College of Medicine-Phoenix. Her clinical expertise encompasses Severe Combined Immunodeficiency (SCID), Infantile Neutropenia, Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Transplant. Dr. Booth is board certified in American Board Of Pediatrics. Dr. Booth is currently accepting new patients.

Melinda Fritz is a Pediatric Hematologist Oncology provider practicing medicine in Summit, New Jersey. Her clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, Hemophilic Arthropathy, and Hemophilia A. Dr. Fritz is board certified in American Board Of Pediatrics. Dr. Fritz is currently accepting new patients.

Nadia Cheek is a Pediatric Hematologist Oncology provider practicing medicine in San Antonio, Texas. Her clinical expertise encompasses Sickle Cell Disease, Acute Lymphoblastic Leukemia (ALL), Hemoglobinopathy, and Congenital Hemolytic Anemia. Dr. Cheek is board certified in American Board Of Pediatrics. Dr. Cheek is currently accepting new patients.

Christopher Lawlor, MD, is an Atlantic Medical Group physician and the Division Chief of Pediatric Hematology and Oncology for the Valerie Fund Children’s Center. Board-certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics, and fellowship-trained in pediatric hematology and oncology, he specializes in blood disorders and cancers in children, adolescents, and young adults, treating children of all ages with benign and malignant disease.Dr. Lawlor has spent over 25 years dedicated to children and helping them overcome serious illness so that they can grow into healthy adults. Prior to coming to Atlantic Medical Group, he served as the medical director for Pediatric Specialists of Virginia Center for Cancer and Blood Disorders and was affiliated with prestigious Children’s National Hospital in the Washington, DC, area. In his accomplished career he has managed the unique needs of infants, children, adolescents, and young adults while employing the latest innovations and breakthroughs to help children with cancer and blood disorders. From diagnosis through recovery, Dr. Lawlor provides family- and child-centered care, ensuring that patients and families receive the supportive services necessary to help them through a critical illness. In addition, he is committed to long-term follow-up care, promoting ongoing health and wellness for pediatric cancer survivors. Dr. Lawlor has collaborated on research in pediatric cancer treatment, authored book chapters, and presented nationally and internationally on many aspects of pediatric hematology and oncology. He is a member of the Children’s Oncology Group and the Histiocyte Society.After earning his medical degree from New York Medical College, Dr. Lawlor completed both his residency and a fellowship in pediatric hematology and oncology at Children’s National Medical Center, Washington, DC, one of the top five children’s hospitals in the nation. He has been listed as a top doctor by the Washingtonian and Northern Virginia Magazine. Dr. Lawlor is a participating provider of the Atlantic Accountable Care Organization. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Osteosarcoma, Ewing Sarcoma, and Immune Thrombocytopenic Purpura (ITP). Dr. Lawlor is board certified in American Board Of Pediatrics. Dr. Lawlor is currently accepting new patients.

Jennifer Ann Kovatch, MD, is a board-certified physician specializing in pediatric hematology oncology.|Dr. Kovatch and her team treat children up to age 13 for conditions such as leukemia/lymphoma, solid tumors, benign tumors and benign hematology (anemia, bleeding disorders and clotting disorders).|Dr. Kovatch performs procedures including lumbar puncture, intrathecal chemotherapy (when chemotherapy is delivered into cerebrospinal fluid), and bone marrow aspiration and biopsy.|She was inspired by her own experience as a pediatric hematology oncology patient to pursue a career in medicine and make a difference in the lives of children. “I love getting to know my patients and helping them achieve their therapeutic goals,” she says.|Dr. Kovatch earned her Doctor of Medicine from the Ross University School of Medicine in the West Indies in 2014. She completed her residency at the University of Missouri in 2017 and a fellowship at the Penn State College of Medicine in 2020.|She is board certified in pediatrics and pediatric hematology oncology by the American Board of Pediatrics.|A New Jersey native, Dr. Kovatch enjoys renovating her home, yardwork and fostering cats in her spare time. Her hobbies include riding her motorcycle and creating artwork. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Immune Thrombocytopenic Purpura (ITP), and Neurofibromatosis Type 1 (NF1). Dr. Kovatch is currently accepting new patients.

Dimarys Sanchez is a Pediatric Hematologist Oncology provider practicing medicine in San Antonio, Texas. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL) and Immune Thrombocytopenic Purpura (ITP). Dr. Sanchez is board certified in American Board Of Pediatrics. Dr. Sanchez is currently accepting new patients.

Dr. Grana specializes in pediatric hematology/oncology in the Johns Hopkins All Children’s Cancer & Blood Disorders Institute. She joined the hospital medical staff in 1992. Dr. Grana earned her medical degree from the University of Puerto Rico School of Medicine. She trained in pediatrics at University Children’s Hospital in San Juan, Puerto Rico, and completed a pediatric hematology/oncology fellowship at the University of Florida. Her clinical expertise encompasses Acute Monoblastic Leukemia (AmoL), Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, and Immune Thrombocytopenic Purpura (ITP). Dr. Grana is board certified in American Board Of Pediatrics. Dr. Grana is currently accepting new patients.

Adam Wolfe is a Pediatric Hematologist Oncology provider practicing medicine in San Antonio, Texas. His clinical expertise encompasses Hepatoblastoma and Acute Lymphoblastic Leukemia (ALL). Dr. Wolfe is board certified in American Board Of Pediatrics. Dr. Wolfe is currently accepting new patients.

Dr. Miller is a board-certified and fellowship-trained specialist in pediatric hematology/oncology. She attended Eastern Virginia Medical School, where she received her medical degree. She completed her residency at Geisinger Medical Center and her fellowship in pediatric hematology and oncology at the University of Iowa Hospitals and Clinics. Dr. Miller is certified by the American Board of Pediatrics in pediatric hematology-oncology. Her clinical expertise encompasses Langerhans Cell Histiocytosis, Neurofibromatosis Type 1 (NF1), and Immune Thrombocytopenic Purpura (ITP). Dr. Miller is board certified in The American Board Of Pediatrics In Pediatric Hematology-Oncology. Dr. Miller is currently accepting new patients.

Joseph Torkildson is a Pediatric Hematologist Oncology provider practicing medicine in Mesa, Arizona. Dr. Torkildson is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Ganglioglioma, Medulloblastoma, Glioma, Reticulohistiocytoma, and Bone Marrow Aspiration. Dr. Torkildson is board certified in American Board Of Pediatrics/Hematology-Oncology and American Board Of Pediatrics. Dr. Torkildson is currently accepting new patients.

I enjoy spending time with my family, cooking, hiking, theatre, scuba and white water rafting. Dr. Pariury is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, Hepatoblastoma, and Bone Marrow Aspiration. Dr. Pariury is board certified in American Board Of Pediatrics/Hematology-Oncology and American Board Of Pediatrics. Dr. Pariury is currently accepting new patients.